|
TRIP4 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.71839994958611E-10 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.659990E-03 |
| Normal-vs-Stage2 |
9.648000E-04 |
| Normal-vs-Stage3 |
3.44169137633799E-15 |
| Normal-vs-Stage4 |
3.74570374717109E-11 |
| Stage1-vs-Stage2 |
7.198100E-02 |
| Stage1-vs-Stage3 |
2.12469997151743E-09 |
| Stage1-vs-Stage4 |
4.07759999987434E-07 |
| Stage2-vs-Stage3 |
3.588500E-02 |
| Stage2-vs-Stage4 |
5.172000E-02 |
| Stage3-vs-Stage4 |
9.416600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.95830085059879E-11 |
| Normal-vs-AfricanAmerican |
1.998320E-02 |
| Normal-vs-Asian |
1.757670E-02 |
| Caucasian-vs-AfricanAmerican |
1.548580E-01 |
| Caucasian-vs-Asian |
9.553600E-01 |
| AfricanAmerican-vs-Asian |
6.509400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.5985884251395E-12 |
| Normal-vs-Female |
1.363050E-04 |
| Male-vs-Female |
3.718600E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.617900E-03 |
| Normal-vs-Age(41-60Yrs) |
1.26119999999119E-07 |
| Normal-vs-Age(61-80Yrs) |
1.92070004345624E-09 |
| Normal-vs-Age(81-100Yrs) |
2.612000E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.946400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.200800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.412200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.916200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.506600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.625400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
4.907600E-02 |
| Normal-vs-Grade 2 |
2.805700E-04 |
| Normal-vs-Grade 3 |
2.19200002593567E-09 |
| Normal-vs-Grade 4 |
1.62447832963153E-12 |
| Grade 1-vs-Grade 2 |
6.245700E-04 |
| Grade 1-vs-Grade 3 |
4.00860000000502E-05 |
| Grade 1-vs-Grade 4 |
1.85890192128113E-11 |
| Grade 2-vs-Grade 3 |
4.436300E-03 |
| Grade 2-vs-Grade 4 |
2.00839345154691E-12 |
| Grade 3-vs-Grade 4 |
8.3643999948535E-08 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
6.669800E-01 |
| Normal-vs-ccB subtype |
<1E-12 |
| ccA subtype-vs-ccB subtype |
<1E-12 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.18870005347571E-09 |
| Normal-vs-N1 |
1.041620E-04 |
| N0-vs-N1 |
2.141800E-02 |
|
|
